Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.
Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, Shimizu T, Kawakami A, Tanaka K, Tsuji T, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, Nakajima H; Japan VEXAS study group.
Kirino Y, et al. Among authors: mishima k.
Rheumatology (Oxford). 2024 Sep 28:keae530. doi: 10.1093/rheumatology/keae530. Online ahead of print.
Rheumatology (Oxford). 2024.
PMID: 39340799